Jared Henderson

458 total citations
14 papers, 131 citations indexed

About

Jared Henderson is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Jared Henderson has authored 14 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jared Henderson's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and CAR-T cell therapy research (4 papers). Jared Henderson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and CAR-T cell therapy research (4 papers). Jared Henderson collaborates with scholars based in United States, Czechia and Germany. Jared Henderson's co-authors include R. Eric Davis, Ondřej Havránek, Dipanjan Ghosh, Jan A. Burger, Jason R. Westin, Zhiqiang Wang, Lisa M. Becker, Jingda Xu, Tomasz Żal and Luhong Sun and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Jared Henderson

11 papers receiving 129 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jared Henderson United States 5 55 52 48 45 38 14 131
Tobias Roider Germany 8 62 1.1× 39 0.8× 79 1.6× 41 0.9× 67 1.8× 19 175
Jennifer A. Arzt United States 4 52 0.9× 58 1.1× 27 0.6× 65 1.4× 64 1.7× 5 151
Verena Kalter Germany 6 39 0.7× 31 0.6× 80 1.7× 79 1.8× 44 1.2× 8 148
Sven Turkalj United Kingdom 5 31 0.6× 31 0.6× 39 0.8× 40 0.9× 47 1.2× 9 114
Julia Gutjahr Austria 6 92 1.7× 31 0.6× 95 2.0× 49 1.1× 47 1.2× 8 174
Stuart J. Blakemore United Kingdom 7 25 0.5× 28 0.5× 42 0.9× 53 1.2× 97 2.6× 9 155
Emma Flordal Thelander Sweden 4 46 0.8× 68 1.3× 25 0.5× 49 1.1× 32 0.8× 4 110
Olga Stehlíková Czechia 7 22 0.4× 40 0.8× 52 1.1× 56 1.2× 51 1.3× 14 146
Tatjana Pandzic Sweden 8 48 0.9× 64 1.2× 26 0.5× 65 1.4× 94 2.5× 14 203
Patrick Henrick United States 7 83 1.5× 31 0.6× 56 1.2× 40 0.9× 76 2.0× 12 166

Countries citing papers authored by Jared Henderson

Since Specialization
Citations

This map shows the geographic impact of Jared Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared Henderson more than expected).

Fields of papers citing papers by Jared Henderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared Henderson. The network helps show where Jared Henderson may publish in the future.

Co-authorship network of co-authors of Jared Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Jared Henderson. A scholar is included among the top collaborators of Jared Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared Henderson. Jared Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Strati, Paolo, Lei Feng, Jason R. Westin, et al.. (2025). Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial. Nature Communications. 16(1). 7300–7300.
2.
Strati, Paolo, Dai Chihara, Jason R. Westin, et al.. (2025). A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma. Clinical Cancer Research. 31(19). 4079–4088.
3.
Strati, Paolo, Lei Feng, Dai Chihara, et al.. (2024). Abstract CT037: A phase I investigator-initiated trial of evorpacept (ALX148), lenalidomide and rituximab for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Cancer Research. 84(7_Supplement). CT037–CT037. 3 indexed citations
4.
Henderson, Jared, et al.. (2023). FAAH inhibition ameliorates breast cancer in a murine model. Oncotarget. 14(1). 910–918. 3 indexed citations
5.
Reville, Patrick K., Enyu Dai, Qing Deng, et al.. (2023). P1366: SAR442257, A CD38/CD28/CD3 TRISPECIFIC ANTIBODY, POTENTIATES CAR T-CELL ACTIVITY AGAINST LARGE B-CELL LYMPHOMA. HemaSphere. 7(S3). e860097f–e860097f. 1 indexed citations
6.
7.
Li, Xubin, Qing Deng, Jared Henderson, et al.. (2022). Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy. Blood. 140(Supplement 1). 4502–4503. 6 indexed citations
8.
Herbrich, Shelley M., Natalia Baran, Tianyu Cai, et al.. (2021). Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML. Journal for ImmunoTherapy of Cancer. 9(7). e002968–e002968. 28 indexed citations
9.
Henderson, Jared, Ondřej Havránek, Man Chun John, et al.. (2021). Detecting Förster resonance energy transfer in living cells by conventional and spectral flow cytometry. Cytometry Part A. 101(10). 818–834. 8 indexed citations
10.
Vanarsa, Kamala, Jared Henderson, Sanam Soomro, et al.. (2020). Upregulation of Proinflammatory Bradykinin Peptides in Systemic Lupus Erythematosus and Rheumatoid Arthritis. The Journal of Immunology. 205(2). 369–376. 11 indexed citations
11.
Doan, Thao, et al.. (2018). Targeting FAAH in hematological and non-hematological cancers. The Journal of Immunology. 200(Supplement_1). 178.20–178.20. 2 indexed citations
12.
Soliman, Samar, et al.. (2018). Serum IGFBP2, IGFBP4, and sTNFR2 are predictive of concurrent clinical and histological nephritis in SLE. The Journal of Immunology. 200(Supplement_1). 174.25–174.25.
13.
Nguyen, Teresa T., Xuejun Fan, Jared Henderson, et al.. (2017). Abstract 3668: Oncolytic adenoviruses expressing OX40L or GITRL immune modulators show antitumor effect on immune-competent mouse breast cancer models. Cancer Research. 77(13_Supplement). 3668–3668. 1 indexed citations
14.
Havránek, Ondřej, Jingda Xu, Stefan Köhrer, et al.. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 130(8). 995–1006. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Roider Breakdown of academic impact, for papers by Jennifer A. Arzt Breakdown of academic impact, for papers by Verena Kalter Breakdown of academic impact, for papers by Sven Turkalj Breakdown of academic impact, for papers by Julia Gutjahr Breakdown of academic impact, for papers by Stuart J. Blakemore Breakdown of academic impact, for papers by Emma Flordal Thelander Breakdown of academic impact, for papers by Olga Stehlíková Breakdown of academic impact, for papers by Tatjana Pandzic Breakdown of academic impact, for papers by Patrick Henrick
Rankless by CCL
2026